AngioDynamics Lacked Approval On Device Feature, 483 States

The GMP Letter
A A
A Form 483 for AngioDynamics of Queensbury, N.Y., states the company distributed a range of devices with flaws or unapproved features.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $135.00